These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 883560)

  • 1. D-Amphetamine-induced inhibition of central dopaminergic neurons: direct effect or mediated by a striatonigral feedback pathway?
    Bunney BS; Aghajanian GK
    Adv Biochem Psychopharmacol; 1977; 16():577-82. PubMed ID: 883560
    [No Abstract]   [Full Text] [Related]  

  • 2. d-Amphetamine-induced depression of central dopamine neurons: evidence for mediation by both autoreceptors and a striato-nigral feedback pathway.
    Bunney BS; Aghajanian GK
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 304(3):255-61. PubMed ID: 714182
    [No Abstract]   [Full Text] [Related]  

  • 3. Indirect evidence for a feedback loop mechanism between two central dopaminergic pathways: preliminary results.
    Yehuda S
    Commun Psychopharmacol; 1979; 3(2):115-9. PubMed ID: 467002
    [No Abstract]   [Full Text] [Related]  

  • 4. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

  • 5. Endogenous DA-mediated feedback inhibition of DA neurons: involvement of both D(1)- and D(2)-like receptors.
    Shi WX; Pun CL; Smith PL; Bunney BS
    Synapse; 2000 Feb; 35(2):111-9. PubMed ID: 10611636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. d-Amphetamine-induced inhibition of central dopaminergic neurons: mediation by a striato-nigral feedback pathway.
    Bunney BS; Achajanian GK
    Science; 1976 Apr; 192(4237):391-3. PubMed ID: 1257777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D & L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons.
    Bunney BS; Walters JR; Kuhar MJ; Roth RH; Aghajanian GK
    Psychopharmacol Commun; 1975; 1(2):177-90. PubMed ID: 1223998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic mechanisms involved in the acute and chronic effect of amphetamine [proceedings].
    Groves PM
    Psychopharmacol Bull; 1977 Jan; 13(1):44-5. PubMed ID: 834819
    [No Abstract]   [Full Text] [Related]  

  • 9. Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons.
    Sotty F; Montezinho LP; Steiniger-Brach B; Nielsen J
    J Neurochem; 2009 May; 109(3):766-75. PubMed ID: 19236563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration.
    Natsume A; Mata M; Goss J; Huang S; Wolfe D; Oligino T; Glorioso J; Fink DJ
    Exp Neurol; 2001 Jun; 169(2):231-8. PubMed ID: 11358438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat.I. Effects on spontaneous activity of striatal neurons.
    Di Loreto S; Florio T; Capozzo A; Napolitano A; Adorno D; Scarnati E
    Exp Neurol; 1996 Apr; 138(2):318-26. PubMed ID: 8620930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the striato-nigral pathway responsible for 'feed-back' control of dopamine release [proceedings]?
    Arbuthnott GW; Garcia-Munoz M; Nicolaou NM; Tulloch IF; Wright AK
    Br J Pharmacol; 1976 Oct; 58(2):272P. PubMed ID: 974393
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
    Li SJ; Sivam SP; McGinty JF; Huang YS; Hong JS
    J Pharmacol Exp Ther; 1987 Nov; 243(2):792-8. PubMed ID: 2445959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of striato-nigral substance P in the regulation of the activity of the nigro-striatal dopaminergic neurons.
    Glowinski J; Michelot R; Chéramy A
    Adv Biochem Psychopharmacol; 1980; 22():51-62. PubMed ID: 6156583
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation.
    Bunney BS; Aghajanian GK
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():249-67. PubMed ID: 826996
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of crus cerebri lesions and repeated amphetamine treatment on the activity of nigral dopaminergic neurons.
    Heidenreich BA; Rebec GV
    Synapse; 2000 Oct; 38(1):80-6. PubMed ID: 10941143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD; Manzino L; Sonsalla PK
    Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.